607 related articles for article (PubMed ID: 32379344)
1. IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa.
Fletcher JM; Moran B; Petrasca A; Smith CM
Clin Exp Immunol; 2020 Aug; 201(2):121-134. PubMed ID: 32379344
[TBL] [Abstract][Full Text] [Related]
2. Single-cell transcriptomics suggest distinct upstream drivers of IL-17A/F in hidradenitis versus psoriasis.
Kim J; Lee J; Li X; Lee HS; Kim K; Chaparala V; Murphy W; Zhou W; Cao J; Lowes MA; Krueger JG
J Allergy Clin Immunol; 2023 Sep; 152(3):656-666. PubMed ID: 37271319
[TBL] [Abstract][Full Text] [Related]
3. The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond.
Brembilla NC; Senra L; Boehncke WH
Front Immunol; 2018; 9():1682. PubMed ID: 30127781
[TBL] [Abstract][Full Text] [Related]
4. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
5. A new T helper 17 cytokine in hidradenitis suppurativa: antimicrobial and proinflammatory role of interleukin-26.
Scala E; Di Caprio R; Cacciapuoti S; Caiazzo G; Fusco A; Tortorella E; Fabbrocini G; Balato A
Br J Dermatol; 2019 Nov; 181(5):1038-1045. PubMed ID: 30829398
[TBL] [Abstract][Full Text] [Related]
6. The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.
Shah A; Alhusayen R; Amini-Nik S
Inflamm Res; 2017 Nov; 66(11):931-945. PubMed ID: 28656364
[TBL] [Abstract][Full Text] [Related]
7. An update on the pathogenesis of hidradenitis suppurativa: implications for therapy.
Negus D; Ahn C; Huang W
Expert Rev Clin Immunol; 2018 Apr; 14(4):275-283. PubMed ID: 29509041
[TBL] [Abstract][Full Text] [Related]
8. The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside.
Liu T; Li S; Ying S; Tang S; Ding Y; Li Y; Qiao J; Fang H
Front Immunol; 2020; 11():594735. PubMed ID: 33281823
[TBL] [Abstract][Full Text] [Related]
9. The role of interleukin-17 in the pathogenesis of hidradenitis suppurativa.
Yao Y; Thomsen SF
Dermatol Online J; 2017 Jul; 23(7):. PubMed ID: 29469692
[TBL] [Abstract][Full Text] [Related]
10. Hidradenitis Suppurativa Is Characterized by Dysregulation of the Th17:Treg Cell Axis, Which Is Corrected by Anti-TNF Therapy.
Moran B; Sweeney CM; Hughes R; Malara A; Kirthi S; Tobin AM; Kirby B; Fletcher JM
J Invest Dermatol; 2017 Nov; 137(11):2389-2395. PubMed ID: 28652108
[TBL] [Abstract][Full Text] [Related]
11. IL-17C amplifies epithelial inflammation in human psoriasis and atopic eczema.
Lauffer F; Jargosch M; Baghin V; Krause L; Kempf W; Absmaier-Kijak M; Morelli M; Madonna S; Marsais F; Lepescheux L; Albanesi C; Müller NS; Theis FJ; Schmidt-Weber C; Eyerich S; Biedermann T; Vandeghinste N; Steidl S; Eyerich K
J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):800-809. PubMed ID: 31793105
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of interleukin-17A in mast cells contributes to the pathogenesis of hidradenitis suppurativa.
Chu CB; Yang CC; Hsueh YY; Chen PC; Hong YK; Kuo YY; Tsai SJ
Br J Dermatol; 2023 Nov; 189(6):719-729. PubMed ID: 37540988
[TBL] [Abstract][Full Text] [Related]
13. IL-17 and its role in inflammatory, autoimmune, and oncological skin diseases: state of art.
Bernardini N; Skroza N; Tolino E; Mambrin A; Anzalone A; Balduzzi V; Colapietra D; Marchesiello A; Michelini S; Proietti I; Potenza C
Int J Dermatol; 2020 Apr; 59(4):406-411. PubMed ID: 31663126
[TBL] [Abstract][Full Text] [Related]
14. The IL-1 Pathway Is Hyperactive in Hidradenitis Suppurativa and Contributes to Skin Infiltration and Destruction.
Witte-Händel E; Wolk K; Tsaousi A; Irmer ML; Mößner R; Shomroni O; Lingner T; Witte K; Kunkel D; Salinas G; Jodl S; Schmidt N; Sterry W; Volk HD; Giamarellos-Bourboulis EJ; Pokrywka A; Döcke WD; Schneider-Burrus S; Sabat R
J Invest Dermatol; 2019 Jun; 139(6):1294-1305. PubMed ID: 30528824
[TBL] [Abstract][Full Text] [Related]
15. Psoriasis and other Th17-mediated skin diseases.
Tokura Y; Mori T; Hino R
J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
[TBL] [Abstract][Full Text] [Related]
16. The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases.
Navarro-Compán V; Puig L; Vidal S; Ramírez J; Llamas-Velasco M; Fernández-Carballido C; Almodóvar R; Pinto JA; Galíndez-Aguirregoikoa E; Zarco P; Joven B; Gratacós J; Juanola X; Blanco R; Arias-Santiago S; Sanz Sanz J; Queiro R; Cañete JD
Front Immunol; 2023; 14():1191782. PubMed ID: 37600764
[TBL] [Abstract][Full Text] [Related]
17. Hidradenitis Suppurativa as a Potential Subtype of Autoinflammatory Keratinization Disease.
Nomura T
Front Immunol; 2020; 11():847. PubMed ID: 32508815
[TBL] [Abstract][Full Text] [Related]
18. Hidradenitis suppurativa - The role of interleukin-17, the aryl hydrocarbon receptor and the link to a possible fungal aetiology.
Yidana DB
Med Hypotheses; 2021 Apr; 149():110530. PubMed ID: 33607406
[TBL] [Abstract][Full Text] [Related]
19. The role of IL 23 in the treatment of psoriasis.
Puig L
Expert Rev Clin Immunol; 2017 Jun; 13(6):525-534. PubMed ID: 28165883
[TBL] [Abstract][Full Text] [Related]
20. The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study.
Vossen ARJV; Ardon CB; van der Zee HH; Lubberts E; Prens EP
Br J Dermatol; 2019 Aug; 181(2):314-323. PubMed ID: 30657173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
